Tennessee Valley Asset Management Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-9
Closed -$7.9K 586
2023
Q4
$7.9K Buy
+9
New +$7.9K ﹤0.01% 492